crizotinib-话题@MedSci - 梅斯（MedSci）

#crizotinib#

10篇内容 | 1025人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1952306, encodeId=90dd1952306ad, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=Target Oncol:真实世界探索Crizotinib（克唑替尼）治疗ROS1阳性晚期非小细胞肺癌（NSCLC）患者的疗效, objectType=article, longId=295679, objectId=7f802956e901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f802956e901, replyNumber=0, likeNumber=77, createdTime=2022-05-25, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f802956e901, moduleTitle=Target Oncol:真实世界探索Crizotinib（克唑替尼）治疗ROS1阳性晚期非小细胞肺癌（NSCLC）患者的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7f802956e901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952305, encodeId=06691952305b1, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=ERJ：(R)-Crizotinib 在动物模型中加剧肺动脉高压, objectType=article, longId=218285, objectId=344521828525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=344521828525, replyNumber=0, likeNumber=77, createdTime=2021-11-16, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=344521828525, moduleTitle=ERJ：(R)-Crizotinib 在动物模型中加剧肺动脉高压, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=344521828525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952304, encodeId=006f1952304d8, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果, objectType=article, longId=217316, objectId=e44421e31653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e44421e31653, replyNumber=0, likeNumber=60, createdTime=2022-08-27, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e44421e31653, moduleTitle=J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e44421e31653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952303, encodeId=a4941952303a3, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=J Clin Oncol：II期临床显示Crizotinib在东亚患者中具有抗肿瘤活性, objectType=article, longId=133918, objectId=05b213391822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05b213391822, replyNumber=0, likeNumber=64, createdTime=2018-04-18, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05b213391822, moduleTitle=J Clin Oncol：II期临床显示Crizotinib在东亚患者中具有抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=05b213391822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952302, encodeId=72d819523028c, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=JCO：crizotinib或称为儿童间变性大细胞淋巴瘤和炎性肌纤维母细胞瘤患者新福音, objectType=article, longId=108276, objectId=b1671082e651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1671082e651, replyNumber=0, likeNumber=66, createdTime=2017-09-17, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1671082e651, moduleTitle=JCO：crizotinib或称为儿童间变性大细胞淋巴瘤和炎性肌纤维母细胞瘤患者新福音, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b1671082e651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952301, encodeId=b0221952301a4, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=NEJM：未经治疗的ALK阳性非小细胞肺癌患者采用Alectinib和Crizotinib治疗的疗效比较！, objectType=article, longId=101153, objectId=1b50101153e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b50101153e0, replyNumber=0, likeNumber=74, createdTime=2017-10-06, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b50101153e0, moduleTitle=NEJM：未经治疗的ALK阳性非小细胞肺癌患者采用Alectinib和Crizotinib治疗的疗效比较！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1b50101153e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952300, encodeId=ecad1952300f3, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=2016NICE技术评估指南：Crizotinib用于未经治疗的间变性淋巴瘤激酶（ALK）阳性的晚期非小细胞肺癌的治疗（TA406）发布, objectType=article, longId=81135, objectId=124781135a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=124781135a7, replyNumber=0, likeNumber=64, createdTime=2017-08-09, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=124781135a7, moduleTitle=2016NICE技术评估指南：Crizotinib用于未经治疗的间变性淋巴瘤激酶（ALK）阳性的晚期非小细胞肺癌的治疗（TA406）发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=124781135a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952298, encodeId=7cce195229879, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=NEJM：克唑替尼(Crizotinib)一线治疗ALK阳性的非鳞癌NSCLC患者显著延长无进展生存期, objectType=article, longId=43675, objectId=ea41436e517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea41436e517, replyNumber=0, likeNumber=79, createdTime=2014-12-22, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea41436e517, moduleTitle=NEJM：克唑替尼(Crizotinib)一线治疗ALK阳性的非鳞癌NSCLC患者显著延长无进展生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ea41436e517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952299, encodeId=60d4195229940, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=Crizotinib对罕见突变的肺癌有效, objectType=article, longId=44111, objectId=2df9441117d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df9441117d, replyNumber=0, likeNumber=80, createdTime=2015-09-22, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df9441117d, moduleTitle=Crizotinib对罕见突变的肺癌有效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2df9441117d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952297, encodeId=4cd0195229e76, content=<a href='/topic/show?id=4b46525119' target=_blank style='color:#2F92EE;'>#crizotinib#</a>, objectTitle=Lancet Oncol：Crizotinib可用于治疗炎性肌纤维母细胞瘤和间变性大细胞淋巴瘤儿童患者, objectType=article, longId=17725, objectId=1c411e72588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c411e72588, replyNumber=0, likeNumber=86, createdTime=2014-03-04, rootId=0, userName=redcrab, userId=85aa264, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c411e72588, moduleTitle=Lancet Oncol：Crizotinib可用于治疗炎性肌纤维母细胞瘤和间变性大细胞淋巴瘤儿童患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1c411e72588)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

crizotinib

2020-05-29

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

Target Oncol:真实世界探索Crizotinib（克唑替尼）治疗ROS1阳性晚期非小细胞肺癌（NSCLC）患者的疗效

2022-05-25

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

ERJ：(R)-Crizotinib 在动物模型中加剧肺动脉高压

2021-11-16

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果

2022-08-27

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

J Clin Oncol：II期临床显示Crizotinib在东亚患者中具有抗肿瘤活性

2018-04-18

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

JCO：crizotinib或称为儿童间变性大细胞淋巴瘤和炎性肌纤维母细胞瘤患者新福音

2017-09-17

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

NEJM：未经治疗的ALK阳性非小细胞肺癌患者采用Alectinib和Crizotinib治疗的疗效比较！

2017-10-06

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

2016NICE技术评估指南：Crizotinib用于未经治疗的间变性淋巴瘤激酶（ALK）阳性的晚期非小细胞肺癌的治疗（TA406）发布

2017-08-09

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

NEJM：克唑替尼(Crizotinib)一线治疗ALK阳性的非鳞癌NSCLC患者显著延长无进展生存期

2014-12-22

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

Crizotinib对罕见突变的肺癌有效

2015-09-22

redcrab (审核中...)

前往app查看评论内容

#crizotinib#

Lancet Oncol：Crizotinib可用于治疗炎性肌纤维母细胞瘤和间变性大细胞淋巴瘤儿童患者

2014-03-04

科室
- - 订阅+
  - 更多科室
工具
服务